Workforce Development in Biomanufacturing The Fundamentals Virtual Course

Workforce Development in Biomanufacturing - The Fundamentals Virtual Course

ISCT Institute of Training and Development - The Global Leader in CGT Workforce Development

ISCT and CMaT have jointly created this nine-week, part-time, virtual training course to train you on the fundamentals and best practices of CGT bio-manufacturing, quality assurance, regulations, bio-processing requirements, product characterization and assessments.

This course consists of a total of 12 hours of on-demand modules and 4 hours of live-virtual discussions with Subject Matter Experts working in leading academic institutes, regulatory agencies, clinical manufacturing laboratories, and industries.

Learn fundamentals and best practices on CGT biomanufacturing, product characterizations, and regulatory-quality framework through on-demand modules and live-virtual discussions. 

course content:
  • Module 1: Stem Cell and Immune Cell Engineering and Therapies
  • Module 2: Quality Assurance and Regulatory Framework
  • Module 2b (Optional Asia Focused Content): Quality Assurance and Regulatory Framework
  • Module 3: Cell Bio-Processing and Manufacturing
  • Module 4: Cell Product Characterization and Importance of Standards

Learning outcome:
  • Understand the therapeutic cell manufacturing approach and applications.
  • Develop knowledge in cell-based therapies and biomanufacturing.
  • Understand the current landscape and gaps in the CGT industry.
  • Learn from CGT experts in academic, clinical, regulatory and industry sectors.

Price (USD):


ISCT or CMaT Member 

Group Member2 Non-Member Group Non-Member2
Academia1 $795 $675.75 $1,295 $1,100.75
Industry $1,495 $1,270.75 $1,895 $1,610.75
(Start-up/Small Company3)
$1,195 $1,015.75 $1,595 $1,355.75
Students $250 $212.50 $595 $505.75

1 Please email ISCT head office at to receive a discount code for Academia Member/Non-Member pricing.
Receive a 15% off when registering for 5 or more people from the same company/institution.

3 Industry Start-Up/Small Company is defined as companies less than 5 years old and has less than 15 employees. Please email ISCT head office at to receive a discount code for Industry (Start-up/Small Company) pricing.

Cancellation Policy: Registration cancellation must be made by email to at least five (5) business days before the course start date. A 10% administrative fee is applied to all cancellations.  Registration fee is non-refundable if it is cancelled within five (5) business days of the course start date.

    Upcoming Course Dates:
    • Sept 27 - Dec 8, 2023
      (registration open)

      Deadline to register: October 4, 2023

    • Feb 12 - April 19, 2024
      Deadline to register: Feb 19, 2024

    • May 27 - Aug 2, 2024
      Deadline to register: June 3, 2024

    • Sept 23 - Nov 29, 2024
      Deadline to register: September 30, 2024

    Designed for:
    • Graduate students
    • Professional looking to learn the fundamentals of CGT manufacturing

    9 weeks, 16 total hours:

    • 12 hours of on-demand modules
    • 4 hours of live-virtual discussions

    Eligibility requirements:
    • None
    upon completion, you will receive:

    • An electronic copy of the course materials.
    • Certificates of course completion from ISCT-CMaT and CMLE.

    *This course has been accepted by the ANSI National Accreditation Board's Certificate Accreditation Program (CAP)

    **ISCT is an ASCP Continuing Medical Laboratory Education (CMLE)-approved provider. This course consists of 16 CMLE credits.

    Already registered?
    access the course HERE

    “ISCT has long identified and taken measures to alleviate the skills shortages across the cell and gene therapy sector. ISCT has run a range of courses across the CGT sector, including forming our ISCT Early-Stage Professionals (ESP) Committee, responsible for our extensive Mentoring Program. Despite these efforts, growth in the CGT sector continues to outpace the professionals entering. This is a major issue for the sector that could become critical in the near future."
    -Bruce Levine, Immediate-Past President, ISCT
    “A well-trained, readily available, diverse workforce is crucial to the success of the emerging cell and gene therapy industry, especially given its highly specialized skill sets, GMP and regulatory requirements, and complex manufacturing and supply chain infrastructure.

    Our partnership with ISCT brings the largest cell manufacturing research and education consortium together with the largest global cell & gene therapy society to deliver critically needed workforce training for CGT. Together, we hope to develop a robust, on-demand, client-centric training platform for industry and clinical manufacturers.”
    -Krishnendu Roy, Robert A. Milton Chair, CMaT